Clinical trials
Not yet recruiting Diabetes Mellitus, Type 2 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 17 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| NYU Langone Health | 2 |
| AdventHealth Translational Research Institute | 1 |
| Eastern Virginia Medical School | 1 |
| First Institute of All Medicines | 1 |
| Harvard School of Public Health (HSPH) | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| KOS Inc. | 1 |
| Loma Linda University | 1 |
| Massachusetts General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 28 |
| Obesity | 7 |
| Overweight | 5 |
| Diabetes Mellitus | 3 |
| Diabetes Mellitus, Type 1 | 2 |
| Hypertension | 2 |
| Prediabetic State | 2 |
| Dyslipidemias | 1 |
| Fatty Liver | 1 |
| Insulin Resistance | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.